The unique short (Us) region of the pseudorabies virus (PRV) genome, which displays high transcriptional activity during the late phase of infection and has been found to code for glycoproteins, is partially deleted in the genomes of three vaccine strains (A57, Norden,. This deletion is located in the Sail subfragment 7A of BamHI fragment 7. To identify possible viral gene products involved in PRV virulence, we investigated the transcriptional and translational pattern of the deleted part of the Us region. Northern blots demonstrated that one major RNA species (3.8 kilobases) transcribed from fragment 7A was missing in the vaccine strains, whereas other transcripts were altered. Radioimmunoprecipitation of in vivo-labeled PRV glycoproteins and of in vitro-translated polypeptides with hyperimmune serum and monoclonal antibodies indicated a lack of glycoprotein gI. Hybrid-selection experiments with subcloned DNA fragments confirmed the absence of gI and of a 40,000-molecular-weight polypeptide. We suggest that both viral proteins are involved in the expression of PRV virulence.
Pseudorabies virus (PRV), the causative agent of Aujeszky's disease, can infect a wide range of animals. Broadly speaking, however, only swine and, more specifically, only older animals can survive a PRV infection concomitant with the establishment of latency. These carrier pigs act as a potent virus reservoir. The increasing prevalence of Aujeszky's disease, especially in Europe, requires the evaluation of attenuated PRV strains used to induce immunity from serious clinical symptoms after subsequent infection with wild-type PRV. Analysis of attenuated strains should provide more insight into the molecular basis of PRV virulence and thus should lead to the development of more defined vaccines. Lomniczi et al. (14) and Hermann et al. (9) have shown that two avirulent virus strains, Bartha and Norden, both display a similar deletion in the unique short involved in virulence. The Us region is very actively transcribed during the late phase of PRV infection (14, 16) , and three glycoproteins, including glycoprotein I (gI), have been shown to be encoded on this region (16, 17, 26) .
We cloned the SalI subfragments 7A and 7B (molecular weights, 3.1 x 106 and 1.3 x 106, respectively) of BamHI fragment 7 of the Us region (26) and used these nicktranslated clones for Southern blot hybridizations (18, 21) with the DNA of either purified virions or virus-infected cells of the vaccine strains (4, 15; map location, Fig. 1 isolated by centrifugation through a CsCl cushion as described previously (7, 16) . Whole-cell RNA (15 ,ug per lane) was denatured with glyoxal, electrophoresed in agarose gels (5) , and transferred to nitrocellulose filters (24) . The filters were incubated in boiling 20 mM Tris hydrochloride (pH 8.0) for 10 min and hybridized as recently described (16) .
After RNA derived from cells infected with wild-type or vaccine virus was probed with nick-translated fragment 7B, the transcriptional pattern of all PRV strains was essentially identical (data not shown). In contrast, hybridization with radioactive fragment 7A revealed some striking differences. All three vaccine strains lacked a major 3.8-kilobase (kb) wild-type transcript (Fig. 2) . Instead of the 2.6-kb RNA of wild-type Phylaxia (Fig. 2, lanes 1 and 2) and strain Norden (Fig. 2, lane 4) , a 2.4-kb RNA was found in strains ( Fig. 2 , lane 5) and A57 (Fig. 2, lane 3 To investigate the expression of the nonglycosylated precursor of gI, pgI, late RNA was isolated from infected cells and used to direct cell-free protein synthesis in a rabbit reticulocyte lysate (New England Nuclear Corp., Boston, Mass.). Radioimmunoprecipitation with the monoclonal antibody 3/6, which specifically precipitates nonglycosylated pgl (16), or with a control monoclonal antibody, 3dB11, directed against a late murine cytomegalovirus protein (unpublished data; gift from U. Koszinowski, Tubingen) and sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis were performed as described previously (11, 12, 15, 16) . The results of these experiments are shown in Fig. 4 . None of the three vaccine strains, Norden (Fig. 4, lane 1) , NIA-4 (Fig. 4, lane 2) , or A57 (Fig. 4, lane 3) , produced late RNA which could be translated into a protein precipitable by the monoclonal antibody, whereas pgl was readily detected after precipitation of the translation products from the virulent PRV strain Phylaxia (Fig. 4, lane 5) . Even prolonged incubation of the in vitro-translated proteins in the presence of the antibody and overexposure of the autoradiograms did not result in the appearance of pgl (data not shown).
The possibility that certain epitopes of this glycoprotein are missing or altered in the vaccine strains, thus preventing its recognition by the monoclonal antibody, was tested by translation in vitro of RNA which was hybrid selected on theSalI subframents. In addition, it was expected that these analyses would demonstrate whether the expression of other genes is affected by the DNA deletion. To this end, total late RNA isolated from infected cells was selected on nitrocellulose filters which contained either Sall subfragment 7A or 7B in 10 mM piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES; pH 6.8)-400 mM NaCI-65% (vol/vol) formamide for 3 h at 56°C. After thorough washing in 1x SSC (0.15 M NaCl plus 0.015 M sodium citrate)-0.5% SDS and subsequently in 2 mM EDTA (pH 7.4) at 60°C, the bound RNA was eluted in boiling distilled water, snap frozen in liquid nitrogen, and ethanol precipitated after the addition of 50 ,ug of yeast tRNA per ml (1, 16) .
Selected RNA was used to direct in vitro translation (Fig.  5) . The results obtained with Phylaxia RNA (Fig. 5A , lanes 1 and 2) or A57 RNA (Fig. 5A, lanes 3 and 4) are shown after hybrid selection with fragment 7A (Fig. 5A, lanes 1 and 3) or 7B (Fig. 5A, lanes 2 and 4) . The fragment 7A-selected Phylaxia RNA codes for polypeptides with molecular weights of 80,000 (80K polypeptide) (representing the pgl), 40,000 and 27,000, whereas only the 27K polypeptide was translated in vitro after corresponding selection of A57 RNA. Neither the 80K pgl nor the 40K protein nor other translation products could be found. We therefore conclude that gI expression and expression of the 40K protein is abolished in the vaccine strain A57. Three fragment 7B-encoded proteins (65K, 60K, and 38K proteins) were found in both the virulent strain Phylaxia and the avirulent strain A57 (Fig. 5A, lanes 2 and 4) . Analyses of the two other vaccine strains yielded similar results. Results of in vitro translation with RNA from strain Norden (Fig. SB, lanes 1  and 2) or strain NIA-4 (Fig. SB, lanes 3 and 4) are shown after hybrid selection with fragment 7A (Fig. 5B, lanes 1 and  3) or fragment 7B (Fig. SB, lanes 2 and 4) . All proteins encoded in fragment 7B were present, although the 38K protein was visible only after overexposure of the autoradiogram. Selection with fragment 7A revealed that NIA-4 closely resembles A57. The pgl and the 40K protein were missing, whereas the 27K polypeptide was expressed ( (Fig. SB, lane   1) . These results prove that the precursor polypeptides of gI are not expressed in any of the vaccine strains tested. These data are in good agreement with our previous mapping studies which localized the gI gene in that part of the genome (16) .
The hybrid-selection experiments allowed the identification of two further polypeptides (40K and 27K) of the virulent strain Phylaxia encoded by fragment 7A. Examination of the three vaccine strains revealed that the 40K polypeptide, whose function during PRV infection is unknown, was consistently absent, whereas the 27K protein Alternatively, the 2.6-kb RNA of strain Norden might be a truncated 3.8-kb transcript as already mentioned.
A further notable difference was observed with respect to the three polypeptides encoded by fragment 7B (65K, 60K, and 38K) which are present in all virus strains. Whereas in strains A57, NIA-4, Phylaxia, and a variety of other PRV strains (data not shown) the most prominent protein has a molecular weight of 65,000, in strain Norden it was slightly larger (69,000; Fig. SB, lane 2) . The 65K protein and the 69K protein were recognized after in vitro translation by an antiserum specific for another PRV glycoprotein (gX). This glycoprotein accumulates in the medium of infected cells (2) , and the coding region thereof has recently been shown to be localized in fragment 7B (17) . The larger pgX, therefore, seems to be characteristic of the vaccine strain Norden.
From the data presented we tentatively conclude that the expression of another PRV glycoprotein (gp5O) also encoded by fragment 7B (26) is not impaired in the vaccine strains. Therefore, of the PRV glycoproteins mapped up to now (16, 17, 19, 26) 
